← Evidence map

ReviewmAbs

The use of CrossMAb technology for the generation of bi- and multispecific antibodies.

Christian Klein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

96 papers cite itlatest 60 shown

2021
2022
2023
2024
2025
2026
pooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 27285945